自噬及肝癌干细胞在肝细胞癌发生发展中的研究进展-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

自噬及肝癌干细胞在肝细胞癌发生发展中的研究进展

Research Advances on Autophagy and Hepatic Cancer Stem Cells in the Pathogenesis and Progression of Hepatocellular Carcinoma.

ES评分 0 浏览量：34 下载量：0

全文阅读下载引用收藏

DOI	10.12208/j.ijcr.20250238
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2025, 9(5)
作者	张思敏¹,杨涓²*,郑盛²,
作者单位	1 大理大学临床医学院云南大理,2 大理大学第二附属医院云南昆明
摘要	肝癌在我国的发病率居高不下，肝细胞癌（hepatocellular carcinoma，HCC）是肝癌最常见的类型[1]。自噬是一种进化保守的细胞内降解过程，通过将细胞内的大分子、过量或受损的细胞器输送到溶酶体进行降解，从而维持细胞稳态，并为细胞生存提供必要的营养物质和生物分子[2]。肝癌干细胞（Liver cancer stem cells，LCSC）具有自我更新和多向分化的能力，并且通过调节干性、耐药性和血管生成，促进HCC的发生和进展[3]。在本文中，我们讨论了自噬及肝癌干细胞在肝细胞癌发生发展中的研究进展。
Abstract	The incidence of liver cancer remains alarmingly high in China, with hepatocellular carcinoma (HCC) being the most prevalent histological type[1]. Autophagy is an evolutionarily conserved intracellular degradation process that maintains cellular homeostasis and provides essential nutrients and biomolecules for cell survival by transporting large molecules, excess or damaged organelles within the cell to lysosomes for degradation.[2]. Liver cancer stem cells (LCSCs), characterized by their self-renewal capacity and multilineage differentiation potential, promote HCC development and progression by regulating stemness, chemoresistance, and angiogenesis[3].In this article, we review the emerging roles of autophagy and hepatic cancer stem cells in the pathogenesis and progression of hepatocellular carcinoma.
关键词	自噬；肝癌干细胞；肝细胞癌；治疗
KeyWord	Autophagy;Liver cancer stem cells;hepatocellular carcinoma;therapies
基金项目
页码	70-74

参考文献
相关文献

[1] 王裕新,潘凯枫,李文庆.2022全球癌症统计报告解读
[J].肿瘤综合治疗电子杂志,2024,10(03):1-16.
[2] Yamamoto H, Matsui T. Molecular Mechanisms of Macroautophagy, Microautophagy, and Chaperone-Mediated Autophagy. J Nippon Med Sch. 2024;91(1):2-9.
[3] Lee TK, Guan XY, Ma S. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications. Nat Rev Gastroenterol Hepatol. 2022;19(1):26-44.
[4] Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345-1362.
[5] Aguilar-Gallardo C, Zamorano M, Farias JG, Quevedo KA. Understanding autophagy role in cancer stem cell development. Mol Biol Rep. 2022;49(7):6741-6751.
[6] Deter RL, De Duve C. Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes. J Cell Biol. 1967;33(2):437-449.
[7] Wang H, Li X, Zhang Q, et al. Autophagy in Disease Onset and Progression. Aging Dis. 2024;15(4):1646-1671.
[8] Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: Regulator of cell death. Cell Death Dis. 2023;14(10):648.
[9] Qian H, Chao X, Williams J, et al. Autophagy in liver diseases: A review. Mol Aspects Med. 2021;82:100973.
[10] Byrnes K, Blessinger S, Bailey NT, Scaife R, Liu G, Khambu B. Therapeutic regulation of autophagy in hepatic metabolism. Acta Pharm Sin B. 2022;12(1):33-49.
[11] Ramachandran A, Akakpo JY, Curry SC, Rumack BH, Jaeschke H. Clinically relevanttherapeutic approaches against acetaminophen hepatotoxicity and acute liver failure. Biochem Pharmacol. 2024;228:116056.
[12] Williams JA, Ding WX. Targeting Pink1-Parkin-mediated mitophagy for treating liver injury. Pharmacol Res. 2015;102:264-269.
[13] Song L, Hou Y, Xu D, et al. Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress. Cell Metab. 2025;37(1):104-120.e9.
[14] Su J, Yuan J, Wang F, Li J, Yue L, Yan M. Advances in the study of viruses inhibiting the production of advanced autophagy or interferon through Rubicon to achieve innate immune escape. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2025 Jan;41(1):83-89.
[15] Wong MM, Chan HY, Aziz NA, et al. Interplay of autophagy and cancer stem cells in hepatocellular carcinoma. Mol Biol Rep. 2021;48(4):3695-3717.
[16] Zdanowicz A, Grosicka-Maciąg E. The Interplay between Autophagy and Mitochondria in Cancer. Int J Mol Sci. 2024;25(17):9143.
[17] Loh JJ, Ma S. Hallmarks of cancer stemness. Cell Stem Cell. 2024;31(5):617-639.
[18] Balaji N, Kukal S, Bhat A, Pradhan N, Minocha S, Kumar S. A quartet of cancer stem cell niches in hepatocellular carcinoma. Cytokine Growth Factor Rev. 2024;79:39-51.
[19] Dai X, Guo Y, Hu Y, et al. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma. Theranostics. 2021;11(7):3489-3501.
[20] Eun J. R. (2025). Overview of hepatocarcinogenesis focusing on cellular origins of livercancer stem cells: a narrative review. Journal of Yeungnam medical science, 42, 3.
[21] Luo J, Gong L, Yang Y, et al. Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC. Hepatology. 2024;79(1):61-78.
[22] Zhao H, Ling Y, He J, et al. Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma. Drug Resist Updat. 2024;74:101084.
[23] Fu X, Zhang Y, Luo Q, Ju Y, Song G. Targeting the mechano-microenvironment and liver cancer stem cells: a promising therapeutic strategy for liver cancer. Cancer Biol Med. 2023;20(11):816-829.
[24] Gungor MZ, Uysal M, Senturk S. The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications. Cancers (Basel). 2022;14(4):940.
[25] Eun JR. Overview of hepatocarcinogenesis focusing on cellular origins of liver cancer stem cells: a narrative review. J Yeungnam Med Sci. 2025;42:3.
[26] Zhou JC, Wang JL, Ren HZ, Shi XL. Autophagy plays a double-edged sword role in liver diseases. J Physiol Biochem. 2022;78(1):9-17.
[27] Park H, Lee S, Lee J, Moon H, Ro SW. Exploring the JAK/STAT signaling pathway in hepatocellular carcinoma: unraveling signaling complexity and therapeutic implications. Int J Mol Sci. 2023;24:13764.
[28] Ma Q, Chen G, Li Y, Guo Z, Zhang X. The molecular genetics of PI3K/PTEN/AKT/mTOR pathway in the malformations of cortical development. Genes Dis. 2023;11(5):101021.
[29] Yuan M, Tu B, Li H, et al. Cancer-associated fibroblasts employ NUFIP1-dependent autophagy to secrete nucleosides and support pancreatic tumor growth. Nat Cancer. 2022;3(8):945-960.
[30] Shi J, Guo C, Li Y, Ma J. The long noncoding RNA TINCR promotes self-renewal of human liver cancer stem cells through autophagy activation. Cell Death Dis. 2022;13(11):961.

引用本文

张思敏,杨涓*,郑盛. 自噬及肝癌干细胞在肝细胞癌发生发展中的研究进展 [J]. 国际临床研究杂志. 2025; 9; (5). 70 - 74.

文献评论

相关学者

相关机构